Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C

Jing Li(Guangzhou University of Chinese Medicine), Swei Sunny Hann(Guangzhou University of Chinese Medicine)
Journal of Experimental & Clinical Cancer Research
May 14, 2015
Cited by 60


Related Papers